Diana Vega

Company: AstraZeneca

Job title: Senior Director - Cancer Biomarker Development

Seminars:

Panel Discussion: Advancing MRD as a Surrogate Endpoint to Streamline Trial Readouts in Hematology Oncology 2:00 pm

Optimizing MRD as a surrogate endpoint in oncology trials Navigating FDA and regulatory expectations around novel endpoints Building successful diagnostic-pharma collaborations to pioneer future trial designsRead more

day: Conference Day 1